Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Sep. 30, 2015 | Oct. 30, 2015 | |
Document And Entity Information | ||
Entity Registrant Name | PRECISION OPTICS CORPORATION, INC. | |
Entity Central Index Key | 867,840 | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2015 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --06-30 | |
Is Entity a Well-known Seasoned Issuer? | No | |
Is Entity a Voluntary Filer? | No | |
Is Entity's Reporting Status Current? | Yes | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 7,434,582 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2,016 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Sep. 30, 2015 | Jun. 30, 2015 |
Current Assets: | ||
Cash and cash equivalents | $ 111,718 | $ 241,051 |
Accounts receivable, net | 459,128 | 588,042 |
Inventories, net | 1,018,727 | 1,073,256 |
Prepaid expenses | 57,988 | 65,182 |
Total current assets | 1,647,561 | 1,967,531 |
Fixed Assets: | ||
Machinery and equipment | 2,435,499 | 2,431,127 |
Leasehold improvements | 553,596 | 553,596 |
Furniture and fixtures | 148,303 | 148,303 |
Vehicles | 19,674 | 19,674 |
Total | 3,157,072 | 3,152,700 |
Less: Accumulated depreciation | (3,102,534) | (3,096,993) |
Net property and equipment | 54,538 | 55,707 |
Patents, net | 20,087 | 18,644 |
TOTAL ASSETS | 1,722,186 | 2,041,882 |
Current Liabilities: | ||
Accounts payable | 871,341 | 912,150 |
Customer advances | 122,300 | 118,800 |
Accrued employee compensation | 192,417 | 222,222 |
Accrued professional services | 95,950 | 60,735 |
Accrued warranty expense | 25,000 | 25,000 |
Other accrued liabilities | 29,857 | 36,087 |
Total current liabilities | 1,336,865 | 1,374,994 |
Stockholders' Equity: | ||
Common Stock, $0.01 par value - Authorized - 50,000,000 shares; Issued and Outstanding - 6,389,806 shares at September 30, 2015 and June 30, 2015 | 63,898 | 63,898 |
Additional paid-in capital | 43,332,823 | 43,232,500 |
Accumulated deficit | (43,011,400) | (42,629,510) |
Total stockholders' equity | 385,321 | 666,888 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 1,722,186 | $ 2,041,882 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2015 | Jun. 30, 2015 |
STOCKHOLDERS' EQUITY | ||
Common Stock par value | $ 0.01 | $ 0.01 |
Common Stock shares authorized | 50,000,000 | 50,000,000 |
Common Stock shares issued | 6,389,806 | 6,389,806 |
Common Stock shares outstanding | 6,389,806 | 6,389,806 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | |
Sep. 30, 2015 | Sep. 30, 2014 | |
Income Statement [Abstract] | ||
Revenues | $ 858,427 | $ 830,714 |
Cost of goods sold | 726,089 | 718,576 |
Gross profit | 132,338 | 112,138 |
Research and development expenses, net | 150,768 | 76,712 |
Selling, general and administrative expenses | 365,026 | 347,147 |
Gain on sale of assets | (1,566) | (15,282) |
Total operating expenses | 514,228 | 408,577 |
Net loss | $ (381,890) | $ (296,439) |
Loss Per Share: | ||
Basic | $ (.06) | $ (.05) |
Diluted | $ (.06) | $ (.05) |
Weighted Average Common Shares Outstanding: | ||
Basic | 6,389,806 | 6,069,131 |
Diluted | 6,389,806 | 6,069,131 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 3 Months Ended | |
Sep. 30, 2015 | Sep. 30, 2014 | |
Cash Flows from Operating Activities: | ||
Net loss | $ (381,890) | $ (296,439) |
Adjustments to reconcile net loss to net cash used in operating activities - | ||
Depreciation and amortization | 5,541 | 3,888 |
Gain on sale of assets | (1,566) | (15,282) |
Stock-based compensation expense | 100,323 | 27,000 |
Non-cash consulting expense | 4,500 | 11,250 |
Changes in operating assets and liabilities - | ||
Accounts receivable, net | 128,914 | (149,252) |
Inventories | 54,529 | 76,929 |
Prepaid expenses | 7,194 | 18,346 |
Accounts payable | (40,809) | (244,207) |
Customer advances | 3,500 | (25,780) |
Accrued expenses | (5,320) | 2,391 |
Net cash used in operating activities | (125,084) | (591,156) |
Cash Flows from Investing Activities: | ||
Additional patent costs | (1,443) | (851) |
Purchases of property and equipment | (4,372) | (31,736) |
Proceeds from sale of assets | 1,566 | 15,282 |
Net cash used in investing activities | (4,249) | (17,305) |
Cash Flows from Financing Activities: | ||
Gross proceeds from July 2014 private placement of common stock | 0 | 980,291 |
Private placement expenses incurred and paid as of September 30, 2015 | 0 | (46,719) |
Net cash provided by financing activities | 0 | 933,572 |
Net increase (decrease) in cash and cash equivalents | (129,333) | 325,111 |
Cash and cash equivalents, beginning of period | 241,051 | 202,380 |
Cash and cash equivalents, end of period | 111,718 | 527,491 |
Supplemental Disclosure of Cash Flow Informatin: | ||
Cash paid for income taxes | 912 | 912 |
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES: | ||
Issuance of 90,298 shares of common stock to consultants | $ 0 | $ 65,016 |
CONSOLIDATED STATEMENTS OF CAS6
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - shares | 3 Months Ended | |
Sep. 30, 2015 | Sep. 30, 2014 | |
Statement of Cash Flows [Abstract] | ||
Stock issued to consultants | 0 | 90,298 |
1. SUMMARY OF SIGNIFICANT ACCOU
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Sep. 30, 2015 | |
Accounting Policies [Abstract] | |
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | Principles of Consolidation and Operations The accompanying consolidated financial statements include the accounts of Precision Optics Corporation, Inc. and its wholly-owned subsidiaries (the Company). All significant intercompany accounts and transactions have been eliminated in consolidation. These consolidated financial statements have been prepared by the Company, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the first quarter of the Companys fiscal year 2016. These consolidated financial statements do not include all disclosures associated with annual consolidated financial statements and, accordingly, should be read in conjunction with footnotes contained in the Companys consolidated financial statements for the year ended June 30, 2015 together with the Report of Independent Registered Public Accounting Firm filed under cover of the Companys 2015 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on October 13, 2015. Use of Estimates The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Income (Loss) Per Share Basic income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period, plus the number of potentially dilutive securities outstanding during the period such as stock options and warrants. For the three months ended September 30, 2015 and 2014, the effect of such securities was antidilutive and not included in the diluted calculation because of the net loss generated in these periods. The following is the calculation of loss per share for the three months ended September 30, 2015 and 2014: Three Months Ended September 30, 2015 2014 Net Loss Basic and Diluted $ (381,890 ) $ (296,439 ) Basic and Diluted Weighted Average Shares Outstanding 6,389,806 6,069,131 Loss Per Share Basic $ (0.06 ) $ (0.05 ) Diluted $ (0.06 ) $ (0.05 ) The number of shares issuable upon the exercise of outstanding stock options and warrants that were excluded from the computation as their effect was antidilutive was approximately 4,349,500 and 3,794,000 for the three months ended September 30, 2015 and 2014, respectively. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the likelihood of utilization of existing deferred tax assets, management has considered historical results of operations and the current operating environment. Based on this evaluation, a full valuation reserve has been provided for the deferred tax assets. |
2. INVENTORIES
2. INVENTORIES | 3 Months Ended |
Sep. 30, 2015 | |
Inventory Disclosure [Abstract] | |
2. INVENTORIES | Inventories are stated at the lower of cost (first-in, first-out) or market and consisted of the following: September 30, 2015 June 30, 2015 Raw Materials $ 475,948 $ 485,266 Work-In-Progress 337,682 388,503 Finished Goods 205,097 199,487 Total Inventories $ 1,018,727 $ 1,073,256 |
3. STOCK-BASED COMPENSATION
3. STOCK-BASED COMPENSATION | 3 Months Ended |
Sep. 30, 2015 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
3. STOCK-BASED COMPENSATION | Stock-based compensation costs recognized during the quarters ended September 30, 2015 and 2014 amounted to $100,323 and $27,000, respectively, and the costs were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2015 - $36,257; 2014 - $27,000), research and development expenses (2015 - $29,391; 2014 - $0) and cost of goods sold (2015 - $34,675; 2014 - $0). No stock-based compensation has been capitalized because such amounts would have been immaterial. There were no stock option grants in the quarter ended September 30, 2015. Information related to the stock options outstanding as of September 30, 2015 is as follows: Range of Exercise Prices Number of Shares Weighted-Average Remaining Contractual Life (years) Weighted-Average Exercise Price Exercisable Number of Shares Exercisable Weighted-Average Exercise Price $ 0.73 319,000 9.64 $ 0.73 106,333 $ 0.73 $ 0.73 330,000 9.64 $ 0.73 137,500 $ 0.73 $ 0.90 35,000 8.78 $ 0.90 20,417 $ 0.90 $ 0.90 30,000 8.78 $ 0.90 30,000 $ 0.90 $ 1.20 207,800 6.42 $ 1.20 207,800 $ 1.20 $ 0.90 9,000 8.26 $ 0.90 9,000 $ 0.90 $ 0.85 9,000 7.26 $ 0.85 9,000 $ 0.85 $ 0.55 44,000 6.37 $ 0.55 44,000 $ 0.55 $ 0.27 40,000 5.79 $ 0.27 40,000 $ 0.27 $ 1.35 1,200 4.15 $ 1.35 1,200 $ 1.35 $ 1.25 1,200 3.16 $ 1.25 1,200 $ 1.25 $ 6.25 1,600 1.16 $ 6.25 1,600 $ 6.25 $ 7.75 1,200 2.16 $ 7.75 1,200 $ 7.75 $ 11.50 800 0.16 $ 11.50 800 $ 11.50 $ 13.75 49,279 0.61 $ 13.75 49,279 $ 13.75 $ 0.27$13.75 1,079,079 8.21 $ 1.43 659,329 $ 1.87 The aggregate intrinsic value of the Companys in-the-money outstanding and exercisable options as of September 30, 2015 was $5,200. |
4. SALE OF STOCK
4. SALE OF STOCK | 3 Months Ended |
Sep. 30, 2015 | |
Equity [Abstract] | |
SALE OF STOCK | On July 1 through July 7, 2014, the Company closed on agreements with institutional and accredited investors (the Investors) for the sale and purchase of 1,717,152 shares of the Companys common stock, $0.01 par value at a purchase price of $0.60 per share (the Shares). The Company received $1,030,291 in gross proceeds from the offering. The Company used the net proceeds from this placement for general working capital purposes. Of this amount, $50,000 was received in June 2014 and the remainder was received in July 2014. In conjunction with the placement, the Company also entered into a registration rights agreement with the Investors, whereby the Company was obligated to file a registration statement with the Securities Exchange Commission on or before forty-five calendar days after July 1, 2014 to register the resale by the Investors of the 1,717,152 shares of the common stock purchased in the placement. Subsequent to the execution of the agreement, the parties agreed to extend the time period by which the Company was obligated to file a registration statement with the Securities Exchange Commission. The registration statement was filed with the Securities Exchange Commission on October 9, 2014, in accordance with the extended timetable, and became effective on October 30, 2014. In conjunction with the offering, certain anti-dilution provisions of the warrants issued in conjunction with the Companys June 25, 2008 and September 28, 2012 financing transactions were triggered. As a result, the number of existing June 25, 2008 warrants increased from 430,678 to 493,398 and the related exercise price of the warrants decreased from $1.18 per share to $1.03 per share. And the number of existing September 28, 2012 warrants increased from 1,944,475 to 2,189,724 and 194,446 to 217,322, respectively, and the related exercise price decreased from $1.25 to $1.11 and from $0.95 to $0.85, respectively. |
5. SALE OF ASSETS
5. SALE OF ASSETS | 3 Months Ended |
Sep. 30, 2015 | |
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract] | |
SALE OF ASSETS | During the quarter ended September 30, 2015, the Company sold equipment that was previously written off for proceeds totaling $1,566, and recorded a gain of $1,566, which is included within operating expenses in the accompanying consolidated statements of operations. |
6. SUBSEQUENT EVENT
6. SUBSEQUENT EVENT | 3 Months Ended |
Sep. 30, 2015 | |
Subsequent Events [Abstract] | |
6. SUBSEQUENT EVENT | On October 19, 2015, the Company entered into agreements with accredited investors for the sale and purchase of 1,044,776 shares of the Companys common stock, $0.01 par value at a purchase price of $0.67 per share. The Company received $700,000 in gross proceeds from the offering. The Company intends to use the net proceeds from this placement for general working capital purposes. In conjunction with the placement, the Company also entered into a registration rights agreement with the investors, whereby the Company is obligated to file a registration statement with the Securities Exchange Commission on or before 90 calendar days after October 19, 2015 to register the resale by the investors of the 1,044,776 shares of the Companys common stock purchased in the placement. In conjunction with the offering, certain anti-dilution provisions of the warrants issued in conjunction with the Companys June 25, 2008 and September 28, 2012 financing transactions were triggered. As a result, the number of existing June 25, 2008 warrants increased from 493,398 to 517,222 and the related exercise price of the warrants decreased from $1.03 to $0.98 per share. Also, as a result of the offering, the number of existing September 28, 2012 warrants increased from 2,189,724 to 2,288,187 and 217,322 to 223,793, respectively, and the related exercise price decreased from $1.11 to $1.06 and from $0.85 to $0.83, respectively. |
1. SUMMARY OF SIGNIFICANT ACC13
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Sep. 30, 2015 | |
Accounting Policies [Abstract] | |
Principles of Consolidation | Principles of Consolidation and Operations The accompanying consolidated financial statements include the accounts of Precision Optics Corporation, Inc. and its wholly-owned subsidiaries (the Company). All significant intercompany accounts and transactions have been eliminated in consolidation. These consolidated financial statements have been prepared by the Company, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the first quarter of the Companys fiscal year 2016. These consolidated financial statements do not include all disclosures associated with annual consolidated financial statements and, accordingly, should be read in conjunction with footnotes contained in the Companys consolidated financial statements for the year ended June 30, 2015 together with the Report of Independent Registered Public Accounting Firm filed under cover of the Companys 2015 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on October 13, 2015. |
Use of Estimates | Use of Estimates The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. |
Income (Loss) per Share | Income (Loss) Per Share Basic income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period, plus the number of potentially dilutive securities outstanding during the period such as stock options and warrants. For the three months ended September 30, 2015 and 2014, the effect of such securities was antidilutive and not included in the diluted calculation because of the net loss generated in these periods. The following is the calculation of loss per share for the three months ended September 30, 2015 and 2014: Three Months Ended September 30, 2015 2014 Net Loss Basic and Diluted $ (381,890 ) $ (296,439 ) Basic and Diluted Weighted Average Shares Outstanding 6,389,806 6,069,131 Loss Per Share Basic $ (0.06 ) $ (0.05 ) Diluted $ (0.06 ) $ (0.05 ) The number of shares issuable upon the exercise of outstanding stock options and warrants that were excluded from the computation as their effect was antidilutive was approximately 4,349,500 and 3,794,000 for the three months ended September 30, 2015 and 2014, respectively. |
Income Taxes | Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the likelihood of utilization of existing deferred tax assets, management has considered historical results of operations and the current operating environment. Based on this evaluation, a full valuation reserve has been provided for the deferred tax assets. |
1. SUMMARY OF SIGNIFICANT ACC14
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Sep. 30, 2015 | |
Accounting Policies [Abstract] | |
Inventories | September 30, 2015 June 30, 2015 Raw Materials $ 475,948 $ 485,266 Work-In-Progress 337,682 388,503 Finished Goods 205,097 199,487 Total Inventories $ 1,018,727 $ 1,073,256 |
Income (Loss) per Share | Three Months Ended September 30, 2015 2014 Net Loss Basic and Diluted $ (381,890 ) $ (296,439 ) Basic and Diluted Weighted Average Shares Outstanding 6,389,806 6,069,131 Loss Per Share Basic $ (0.06 ) $ (0.05 ) Diluted $ (0.06 ) $ (0.05 ) |
2. INVENTORIES (Tables)
2. INVENTORIES (Tables) | 3 Months Ended |
Sep. 30, 2015 | |
Inventory Disclosure [Abstract] | |
Schedule of inventory | September 30, 2015 June 30, 2015 Raw Materials $ 475,948 $ 485,266 Work-In-Progress 337,682 388,503 Finished Goods 205,097 199,487 Total Inventories $ 1,018,727 $ 1,073,256 |
3. STOCK-BASED COMPENSATION (Ta
3. STOCK-BASED COMPENSATION (Tables) | 3 Months Ended |
Sep. 30, 2015 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock options outstanding | Range of Exercise Prices Number of Shares Weighted-Average Remaining Contractual Life (years) Weighted-Average Exercise Price Exercisable Number of Shares Exercisable Weighted-Average Exercise Price $ 0.73 319,000 9.64 $ 0.73 106,333 $ 0.73 $ 0.73 330,000 9.64 $ 0.73 137,500 $ 0.73 $ 0.90 35,000 8.78 $ 0.90 20,417 $ 0.90 $ 0.90 30,000 8.78 $ 0.90 30,000 $ 0.90 $ 1.20 207,800 6.42 $ 1.20 207,800 $ 1.20 $ 0.90 9,000 8.26 $ 0.90 9,000 $ 0.90 $ 0.85 9,000 7.26 $ 0.85 9,000 $ 0.85 $ 0.55 44,000 6.37 $ 0.55 44,000 $ 0.55 $ 0.27 40,000 5.79 $ 0.27 40,000 $ 0.27 $ 1.35 1,200 4.15 $ 1.35 1,200 $ 1.35 $ 1.25 1,200 3.16 $ 1.25 1,200 $ 1.25 $ 6.25 1,600 1.16 $ 6.25 1,600 $ 6.25 $ 7.75 1,200 2.16 $ 7.75 1,200 $ 7.75 $ 11.50 800 0.16 $ 11.50 800 $ 11.50 $ 13.75 49,279 0.61 $ 13.75 49,279 $ 13.75 $ 0.27$13.75 1,079,079 8.21 $ 1.43 659,329 $ 1.87 |
1. SUMMARY OF SIGNIFICANT ACC17
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Loss per share) - USD ($) | 3 Months Ended | |
Sep. 30, 2015 | Sep. 30, 2014 | |
Accounting Policies [Abstract] | ||
Net Loss - Basic and Diluted | $ (381,890) | $ (296,439) |
Basic Weighted Average Shares Outstanding | 6,389,806 | 6,069,131 |
Loss Per Share | ||
Basic | $ (.06) | $ (.05) |
Diluted | $ (.06) | $ (.05) |
1. SUMMARY OF SIGNIFICANT ACC18
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares | 3 Months Ended | |
Sep. 30, 2015 | Sep. 30, 2014 | |
Accounting Policies [Abstract] | ||
Outstanding stock options and warrants that were excluded from the computation as their effect was antidilutive | 4,349,500 | 3,794,000 |
2. INVENTORIES (Details)
2. INVENTORIES (Details) - USD ($) | Sep. 30, 2015 | Jun. 30, 2015 |
Inventory Disclosure [Abstract] | ||
Raw materialS | $ 475,948 | $ 485,266 |
Work-in-progress | 337,682 | 388,503 |
Finished goods | 205,097 | 199,487 |
Total inventories | $ 1,018,727 | $ 1,073,256 |
3. STOCK-BASED COMPENSATION (De
3. STOCK-BASED COMPENSATION (Details) | 3 Months Ended |
Sep. 30, 2015$ / sharesshares | |
Stock Options | |
Range of exercise prices | $0.27-$13.75 |
Number of shares outstanding | 1,079,079 |
Weighted average contractual life | 8 years 2 months 16 days |
Weighted average exercise price | $ / shares | $ 1.43 |
Exercisable number of shares | 659,329 |
Exercisable weighted average exercise price | $ / shares | $ 1.87 |
Option 1 | |
Range of exercise prices | 0.73 |
Number of shares outstanding | 319,000 |
Weighted average contractual life | 9 years 7 months 20 days |
Weighted average exercise price | $ / shares | $ .73 |
Exercisable number of shares | 106,333 |
Exercisable weighted average exercise price | $ / shares | $ 0.73 |
Option 2 | |
Range of exercise prices | 0.73 |
Number of shares outstanding | 330,000 |
Weighted average contractual life | 9 years 7 months 20 days |
Weighted average exercise price | $ / shares | $ .73 |
Exercisable number of shares | 137,500 |
Exercisable weighted average exercise price | $ / shares | $ 0.73 |
Option 3 | |
Range of exercise prices | 0.90 |
Number of shares outstanding | 35,000 |
Weighted average contractual life | 8 years 9 months 11 days |
Weighted average exercise price | $ / shares | $ .90 |
Exercisable number of shares | 20,417 |
Exercisable weighted average exercise price | $ / shares | $ 0.90 |
Option 4 | |
Range of exercise prices | 0.90 |
Number of shares outstanding | 30,000 |
Weighted average contractual life | 8 years 9 months 11 days |
Weighted average exercise price | $ / shares | $ .90 |
Exercisable number of shares | 30,000 |
Exercisable weighted average exercise price | $ / shares | $ 0.90 |
Option 5 | |
Range of exercise prices | 1.20 |
Number of shares outstanding | 207,800 |
Weighted average contractual life | 6 years 5 months 1 day |
Weighted average exercise price | $ / shares | $ 1.20 |
Exercisable number of shares | 207,800 |
Exercisable weighted average exercise price | $ / shares | $ 1.20 |
Option 6 | |
Range of exercise prices | 0.90 |
Number of shares outstanding | 9,000 |
Weighted average contractual life | 8 years 3 months 4 days |
Weighted average exercise price | $ / shares | $ .90 |
Exercisable number of shares | 9,000 |
Exercisable weighted average exercise price | $ / shares | $ 0.90 |
Option 7 | |
Range of exercise prices | 0.85 |
Number of shares outstanding | 9,000 |
Weighted average contractual life | 7 years 3 months 4 days |
Weighted average exercise price | $ / shares | $ .85 |
Exercisable number of shares | 9,000 |
Exercisable weighted average exercise price | $ / shares | $ 0.85 |
Option 8 | |
Range of exercise prices | 0.55 |
Number of shares outstanding | 44,000 |
Weighted average contractual life | 6 years 4 months 13 days |
Weighted average exercise price | $ / shares | $ .55 |
Exercisable number of shares | 44,000 |
Exercisable weighted average exercise price | $ / shares | $ 0.55 |
Option 9 | |
Range of exercise prices | 0.27 |
Number of shares outstanding | 40,000 |
Weighted average contractual life | 5 years 9 months 14 days |
Weighted average exercise price | $ / shares | $ .27 |
Exercisable number of shares | 40,000 |
Exercisable weighted average exercise price | $ / shares | $ 0.27 |
Option 10 | |
Range of exercise prices | 1.35 |
Number of shares outstanding | 1,200 |
Weighted average contractual life | 4 years 1 month 24 days |
Weighted average exercise price | $ / shares | $ 1.35 |
Exercisable number of shares | 1,200 |
Exercisable weighted average exercise price | $ / shares | $ 1.35 |
Option 11 | |
Range of exercise prices | 1.25 |
Number of shares outstanding | 1,200 |
Weighted average contractual life | 3 years 1 month 28 days |
Weighted average exercise price | $ / shares | $ 1.25 |
Exercisable number of shares | 1,200 |
Exercisable weighted average exercise price | $ / shares | $ 1.25 |
Option 12 | |
Range of exercise prices | 6.25 |
Number of shares outstanding | 1,600 |
Weighted average contractual life | 1 year 1 month 28 days |
Weighted average exercise price | $ / shares | $ 6.25 |
Exercisable number of shares | 1,600 |
Exercisable weighted average exercise price | $ / shares | $ 6.25 |
Option 13 | |
Range of exercise prices | 7.75 |
Number of shares outstanding | 1,200 |
Weighted average contractual life | 2 years 1 month 28 days |
Weighted average exercise price | $ / shares | $ 7.75 |
Exercisable number of shares | 1,200 |
Exercisable weighted average exercise price | $ / shares | $ 7.75 |
Option 14 | |
Range of exercise prices | 11.50 |
Number of shares outstanding | 800 |
Weighted average contractual life | 1 month 28 days |
Weighted average exercise price | $ / shares | $ 11.50 |
Exercisable number of shares | 800 |
Exercisable weighted average exercise price | $ / shares | $ 11.50 |
Option 15 | |
Range of exercise prices | 13.75 |
Number of shares outstanding | 49,279 |
Weighted average contractual life | 7 months 10 days |
Weighted average exercise price | $ / shares | $ 13.75 |
Exercisable number of shares | 49,279 |
Exercisable weighted average exercise price | $ / shares | $ 13.75 |
3. STOCK-BASED COMPENSATION (21
3. STOCK-BASED COMPENSATION (Details Narrative) - USD ($) | 3 Months Ended | |
Sep. 30, 2015 | Sep. 30, 2014 | |
Stock-based compensation costs | $ 100,323 | $ 27,000 |
Options granted | 0 | |
Aggregate intrinsic value of "in the money" outstanding | $ 5,200 | |
Aggregate intrinsic value of "in the money" exercisable | 5,200 | |
Selling, General and Administrative Expenses | ||
Stock-based compensation costs | 36,257 | 27,000 |
Research and Development Expenses | ||
Stock-based compensation costs | 29,391 | 0 |
Cost of Goods Sold | ||
Stock-based compensation costs | $ 34,675 | $ 0 |
4. SALE OF STOCK (Details Narra
4. SALE OF STOCK (Details Narrative) - USD ($) | 3 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2015 | |
Stock issued new shares | 1,717,152 | |
Stock issued, value | $ 1,030,291 | |
June 25, 2008 Warrants | ||
Warrants outstanding | 493,398 | |
Warrant exercise price | $ 1.03 | |
September 28, 2012 Warrants | ||
Warrants outstanding | 2,189,724 | |
Warrant exercise price | $ 1.11 | |
September 28, 2012 Warrants 2 | ||
Warrants outstanding | 217,322 | |
Warrant exercise price | $ 0.85 |
5. SALE OF ASSETS (Details Narr
5. SALE OF ASSETS (Details Narrative) - USD ($) | 3 Months Ended | |
Sep. 30, 2015 | Sep. 30, 2014 | |
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract] | ||
Proceeds from sale of assets | $ 1,566 | $ 15,282 |
Gain on sale of assets | $ 1,566 | $ 15,282 |